Northwire Canada EditionTuesday, July 14, 2026
Sign inSubscribe
Northwire
⌕
WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8% WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8%

Healthcare

Page 46
  1. Mar 18, 2026 · 07:30 · MDNA

    Medicenna to Present Preclinical Data from its First-in-Class Tumor Anchored and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the AACR Annual Meeting 2026

    Medicenna to Present Preclinical Data from its First-in-Class Tumor Anchored and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the AACR Annual Meeting 2026

    01
  2. Mar 18, 2026 · 07:08 · FRX

    Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026

    Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026

    02
  3. Mar 18, 2026 · 07:01 · MRVL

    Marvel Biosciences Receives Notice of Allowance for US Patent Application Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204

    Marvel Biosciences Receives Notice of Allowance for US Patent Application Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204

    03
  4. Mar 18, 2026 · 06:31 · CHS

    Comprehensive Healthcare Systems Advances Strategic Roadmap with New Artificial Intelligence Initiative

    Comprehensive Healthcare Systems Advances Strategic Roadmap with New Artificial Intelligence Initiative

    04
  5. Mar 17, 2026 · 18:26 · VPT

    Ventripoint, FLH expand AI cardiac care to remote areas

    Ventripoint, FLH expand AI cardiac care to remote areas

    05
  6. Mar 17, 2026 · 18:02 · AIDR

    Rocket Doctor AI receives $1.94M from warrant exercise

    Rocket Doctor AI receives $1.94M from warrant exercise

    06
  7. Mar 17, 2026 · 17:55 · OPEN

    Opensesame talks Vector RTO, arranges $3M financing

    Opensesame talks Vector RTO, arranges $3M financing

    07
  8. Mar 17, 2026 · 17:30 · GUD

    Knight wins Anvisa approval for Minjuvi use in Brazil

    Knight wins Anvisa approval for Minjuvi use in Brazil

    08
  9. Mar 17, 2026 · 17:18 · GUD

    Knight Therapeutics seeks OK for new Minjuvi indication

    Knight Therapeutics seeks OK for new Minjuvi indication

    09
  10. Mar 17, 2026 · 17:02 · NPTH

    Neupath Health to release 2025 results March 26

    Neupath Health to release 2025 results March 26

    10
  11. Mar 17, 2026 · 16:59 · KNE

    Kane Biotech highlights data on revyve biofilm action

    Kane Biotech highlights data on revyve biofilm action

    11
  12. Mar 17, 2026 · 15:01 · WELL

    Well Health unit closes acquisitions in Ontario, Quebec

    Well Health unit closes acquisitions in Ontario, Quebec

    12
  13. Mar 17, 2026 · 12:41 · EPRX

    Eupraxia posts 24-week data in high-dose Resolve cohort

    Eupraxia posts 24-week data in high-dose Resolve cohort

    13
  14. Mar 17, 2026 · 11:20 · BNXT

    Bionxt signs LOI for cladribine commercialization

    Bionxt signs LOI for cladribine commercialization

    14
← Newer Older →